This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Yale University. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Faye A. Rogers: Innovator in Cancer Therapeutics
Introduction
Faye A. Rogers is a prominent inventor based in Norwalk, CT (US). She has made significant contributions to the field of cancer research, particularly in developing innovative therapeutic strategies. With a focus on gene amplification and targeted apoptosis, her work aims to improve treatment outcomes for cancer patients.
Latest Patents
Faye A. Rogers holds 3 patents that showcase her groundbreaking research. Her latest patents include "Targeting gene amplification in cancer using triplex formation as a therapeutic strategy." This patent discloses methods and agents for treating cancer by utilizing p53-independent apoptosis to reduce the number of p53-depleted or p53-mutated cancer cells that have amplified the HER2 gene. Additionally, it addresses treatment methods for HER2-positive cancer in individuals with Li-Fraumeni Syndrome. Another significant patent is "Gene-targeted apoptosis," which describes methods of triplex-induced apoptosis. This involves forming multiple triplexes in target cells characterized by gene amplification, leading to induced apoptosis in those cells.
Career Highlights
Faye A. Rogers has established herself as a leading figure in cancer research. Her innovative approaches have garnered attention in the scientific community, and her patents reflect her commitment to advancing therapeutic strategies. She is affiliated with Yale University, where she continues her research and development efforts.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Faye A. Rogers is a trailblazer in the field of cancer therapeutics, with her patents paving the way for new treatment methodologies. Her work exemplifies the impact of innovative research on improving patient care in oncology.